Cargando…

IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice

The availability of a highly purified and well characterized circumsporozoite protein (CSP) is essential to improve upon the partial success of recombinant CSP-based malaria vaccine candidates. Soluble, near full-length, Plasmodium falciparum CSP vaccine antigen (CS/D) was produced in E. coli under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwenk, Robert, DeBot, Margot, Porter, Michael, Nikki, Jennifer, Rein, Lisa, Spaccapelo, Roberta, Crisanti, Andrea, Wightman, Paul D., Ockenhouse, Christian F., Dutta, Sheetij
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208815/ https://www.ncbi.nlm.nih.gov/pubmed/25343487 http://dx.doi.org/10.1371/journal.pone.0111020

Ejemplares similares

Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses
por: Khan, Farhat, et al.
Publicado: (2015)

IMRAS—Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS
por: Sedegah, Martha, et al.
Publicado: (2021)

In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
por: Livingstone, Merricka C., et al.
Publicado: (2021)

Seroprevalence of Antibodies against Plasmodium falciparum Sporozoite Antigens as Predictive Disease Transmission Markers in an Area of Ghana with Seasonal Malaria Transmission
por: Kusi, Kwadwo A., et al.
Publicado: (2016)

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum
por: Beutler, Nathan, et al.
Publicado: (2022)

Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
por: Scally, Stephen W., et al.
Publicado: (2018)

Sporozoite motility as a quantitative readout for anti-CSP antibody inhibition
por: de Korne, C. M., et al.
Publicado: (2022)

Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites
por: Schats, Remko, et al.
Publicado: (2015)

Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component
por: Tamminga, Cindy, et al.
Publicado: (2011)

CSP—A Model for In Vivo Presentation of Plasmodium berghei Sporozoite Antigens by Hepatocytes
por: Balam, Saidou, et al.
Publicado: (2012)

Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children
por: Kurtovic, Liriye, et al.
Publicado: (2018)

Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites
por: Atre, Tanmaya, et al.
Publicado: (2019)

Epitope-coated polymer particles elicit neutralising antibodies against Plasmodium falciparum sporozoites
por: Evert, Benjamin J., et al.
Publicado: (2021)

Rhesus macaque and mouse models for down-selecting circumsporozoite protein based malaria vaccines differ significantly in immunogenicity and functional outcomes
por: Phares, Timothy W., et al.
Publicado: (2017)

Cytotoxic Markers Associate With Protection Against Malaria in Human Volunteers Immunized With Plasmodium falciparum Sporozoites
por: Bijker, Else M., et al.
Publicado: (2014)

Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
por: Mallory, Katherine L., et al.
Publicado: (2021)

Whole sporozoite immunization with Plasmodium falciparum strain NF135 in a randomized trial
por: van der Boor, Saskia C., et al.
Publicado: (2023)

Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults
por: Sedegah, Martha, et al.
Publicado: (2011)

A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity
por: Thai, Elaine, et al.
Publicado: (2020)

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
por: de Camargo, Tarsila Mendes, et al.
Publicado: (2018)

Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2
Publicado: (1995)

An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens
por: Rodríguez-Galán, Ana, et al.
Publicado: (2017)

Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice
por: Li, Xiangming, et al.
Publicado: (2016)

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
por: Chuang, Ilin, et al.
Publicado: (2013)

The Development of Whole Sporozoite Vaccines for Plasmodium falciparum Malaria
por: Itsara, Leslie S., et al.
Publicado: (2018)

Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum
por: Behet, Marije C, et al.
Publicado: (2014)

Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults
por: Jongo, Said A., et al.
Publicado: (2018)

Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics
por: Swearingen, Kristian E., et al.
Publicado: (2016)

Novel approaches to whole sporozoite vaccination against malaria(✩)
por: Bijker, Else M., et al.
Publicado: (2015)

Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation
por: Kusi, Kwadwo A, et al.
Publicado: (2014)

A First for Human Vaccinology: GMP Compliant Radiation Attenuation of Plasmodium falciparum Sporozoites for Production of a Vaccine Against Malaria
por: James, Eric R., et al.
Publicado: (2022)

Anti-TRAP/SSP2 monoclonal antibodies can inhibit sporozoite infection and may enhance protection of anti-CSP monoclonal antibodies
por: Wilder, Brandon K., et al.
Publicado: (2022)

A Role for Immune Responses against Non-CS Components in the Cross-Species Protection Induced by Immunization with Irradiated Malaria Sporozoites
por: Mauduit, Marjorie, et al.
Publicado: (2009)

ReverCSP: Time-Travelling in CSP Computations
por: Galindo, Carlos, et al.
Publicado: (2020)

Molecular and functional properties of human Plasmodium falciparum CSP C‐terminus antibodies
por: Oludada, Opeyemi Ernest, et al.
Publicado: (2023)

Development of an attenuated sporozoite vaccine to prevent and eliminate Plasmodium falciparum malaria
por: Billingsley, Peter F
Publicado: (2010)

Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
por: Richie, Thomas L., et al.
Publicado: (2015)

Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens
por: Fonseca, Ana Maria, et al.
Publicado: (2017)

Release of Plasmodium sporozoites requires proteins with histone-fold dimerization domains
por: Currà, Chiara, et al.
Publicado: (2016)

Safety and Comparability of Controlled Human Plasmodium falciparum Infection by Mosquito Bite in Malaria-Naïve Subjects at a New Facility for Sporozoite Challenge
por: Talley, Angela K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hdt6l9plnq45439loltlsq95n3